These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8562272)

  • 1. [The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
    Leonetti G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():74S-77S. PubMed ID: 8562272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
    Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G
    J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of carotid atherosclerosis in hypertension: preliminary baseline data from the European Lacidipine Study on Atheroscelerosis (ELSA).
    Zanchetti A
    Blood Press Suppl; 1996; 4():30-5. PubMed ID: 8973780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid JL; Rodicio J; Safar M; Eckes L; Rizzini P;
    Circulation; 2002 Nov; 106(19):2422-7. PubMed ID: 12417537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A; Hennig M; Hollweck R; Bond G; Tang R; Cuspidi C; Parati G; Facchetti R; Mancia G
    Circulation; 2009 Sep; 120(12):1084-90. PubMed ID: 19738145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
    Zanchetti A; Bond MG; Hennig M; Neiss A; Mancia G; Dal Palù C; Hansson L; Magnani B; Rahn KH; Reid J; Rodicio J; Safar M; Eckes L; Ravinetto R
    J Hypertens; 1998 Jul; 16(7):949-61. PubMed ID: 9794735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    Circulation; 2012 Jul; 126(5):569-78. PubMed ID: 22761453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
    Bond MG; Mercuri M
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S11-6. PubMed ID: 8852539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the benefits of an antihypertensive agent using trials based on event and organ damage: the Systolic Hypertension in the Elderly Long-term Lacidipine (SHELL) trial and the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A
    J Hypertens Suppl; 1995 Dec; 13(4):S35-9. PubMed ID: 8824685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A
    J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
    Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.
    Mancia G; Facchetti R; Parati G; Zanchetti A
    J Hypertens; 2012 Jun; 30(6):1241-51. PubMed ID: 22499291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
    Zanchetti A; Bond MG; Hennig M; Tang R; Hollweck R; Mancia G; Eckes L; Micheli D;
    J Hypertens; 2004 Jun; 22(6):1201-12. PubMed ID: 15167456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
    Giannattasio C; Failla M; Hennig M; Hollweck R; Laurent S; Mallion JM; Reid J; Safar M; Bond G; Zanchetti A; Mancia G
    J Hypertens; 2005 Mar; 23(3):557-62. PubMed ID: 15716697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 18. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ; Castaigne A; de Leeuw PW; Mancia G; Rosenthal T; Ruilope LM
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.